Isla-moos
Producer: Engelhard Arzneimittel GmbH&Co.KG Germany
Code of automatic telephone exchange: R02AA20
Release form: Firm dosage forms. Pastils.
General characteristics. Structure:
Active agent: water extract of the Icelandic moss (0,4-0,8:1) 80 mg.
Pharmacological properties:
Isla-Mint and Isla-Moos contains extract from a medicinal plant of Cetraria islandica (the Icelandic moss) which at the time of ancient civilizations was well known thanks to the salutary therapeutic action at inflammatory respiratory diseases in drugs.
The medical effect of drugs Isla-Mint and Isla-Moos at catarral respiratory diseases is based, first of all, on antimicrobic activity and the immunostimulating properties of plant extract which contains in it that is proved by results of scientific research. As drugs Isla-Mint and Isla-Moos have also protective properties, they can be applied also with the preventive purpose, for example at special sensitivity of respiratory tracts or at the raised load of them (including at sports activities).
The polysaccharides which are contained in drug envelop mucous membranes of pneumatic ways and effectively protect them from influence of harmful external factors and various type of irritants.
When there is a danger of cold, preventive use of drugs Isla-Mint and Isla-Moos, capable to protect mucous membranes, can reduce exposure of different respiratory tracts to infections. Drug does not irritate a stomach.
Indications to use:
• cough, including at bronchitis; hoarseness (laryngitis, pharyngitis); OH (as supportive application);
• strong load of phonatory bands (at singers, teachers, lecturers);
• dryness of mucous membranes in the dry atmosphere of living rooms or in insufficiently humidified office rooms during the heating period, and also at limited nasal breath or during the sports occupations.
Route of administration and doses:
To adults and children 12 years on 1 pastil each hour (to 12 pastils a day), to children at the age of 4–12 years — on 1 pastil each 2 h are aged more senior (to 6 pastils a day), allowing them to be dissolved slowly in a mouth.
Thanks to good tolerance of medicines Isla-Mint and Isla-Moos they can be applied without any fears for a long time.
Besides, even after disappearance of symptoms of a disease Isla-Mint and Isla-Moos it is necessary to accept some more days for achievement of steady therapeutic effect.
If within 4–5 days steady symptoms of a disease do not decrease or, on the contrary, worsen, at emergence of an asthma, fever, and also a purulent and bloody phlegm, it is necessary to consult immediately with the doctor.
Features of use:
The plant extracts which are contained in drugs Isla-Mint and Isla-Moos can sometimes be the cause of deviations in color and taste of this medicine that, however, does not affect its therapeutic action in any way.
Drugs Isla-Mint and Isla-Moos do not contain sugar therefore it is possible to appoint them a sick diabetes mellitus.
1 pastil corresponds 0,03 XE = 0,385 g of carbohydrates.
Use during pregnancy and feeding by a breast. Data on negative influence of drug during pregnancy and feeding by a breast did not arrive. However special researches at this category of patients were not conducted therefore before use of drug it is necessary to weigh a ratio risk/advantage.
Ability to influence speed of response at control of vehicles or other mechanisms. If to accept drug according to the instruction on a medical use, then no negative effects of its use are supposed.
Children. Drug is intended for children aged 4 years as pastils need to be held in a mouth are more senior, allowing them to be dissolved slowly.
Side effects:
In rare instances there can be allergic reactions.
Very seldom drug can have laxative effect on sensitive patients as contains sorbite.
Interaction with other medicines:
So far are unknown.
Contraindications:
In the presence of a fenilketonuriya it is necessary to consider that drug contains sweet substance aspartame. Intolerance of fructose. Hypersensitivity to any ingredient of drug.
Overdose:
Messages on cases of overdose did not arrive.
Storage conditions:
To store at a temperature not above 25 °C in the dry place.
Issue conditions:
Without recipe
Packaging:
Pastils of 80 mg, No. 30.